Back to Search
Start Over
Price variability of TNF‐α inhibitor biosimilars among European countries.
- Source :
- Journal of the European Academy of Dermatology & Venereology; Aug2024, Vol. 38 Issue 8, pe663-e665, 3p
- Publication Year :
- 2024
-
Abstract
- This article discusses the price variability of TNF-α inhibitor biosimilars for the treatment of psoriasis across European countries. The study found that there is significant price variability, with lower prices in Italy and Spain compared to Germany, France, and Denmark. The pricing policies adopted by different countries, such as mandatory discounts, progressive price discounts, and tendering or direct contracting, contribute to this variability. The findings highlight the potential impact on healthcare costs and patient access to biological treatment. However, it is important to note that the study only included one center per country. [Extracted from the article]
- Subjects :
- PRICES
BIOSIMILARS
ADALIMUMAB
SUSTAINABILITY
PSORIATIC arthritis
VALUE-added tax
Subjects
Details
- Language :
- English
- ISSN :
- 09269959
- Volume :
- 38
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- Journal of the European Academy of Dermatology & Venereology
- Publication Type :
- Academic Journal
- Accession number :
- 178646457
- Full Text :
- https://doi.org/10.1111/jdv.19756